Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Michael Lim Joon"'
Autor:
Prabhakar Ramachandran, Tomas Kron, Daryl Jones, Michael Lim Joon, Michal Schneider, Richard Oates, Farshad Foroudi, Suki Gill
Publikováno v:
Journal of Medical Radiation Sciences
Introduction Our department commonly uses a planning target volume (PTV) expansion of 6 mm posterior and 1 cm in all other directions when treating prostate cancer patients with image-guided radiotherapy (IGRT). This study aimed to test the adequacy
Autor:
Daisy Mak, Joanne McNamara, Michael Chao, M. Feigen, Michael Lim Joon, Aurora M T Poon, Patricia Jenkins, Andrew See, Daryl Lim Joon, A Mercuri, Morikatsu Wada, Vincent Khoo
Publikováno v:
Radiotherapy and Oncology. 97:205-211
Purpose To assess the correlation of 18F-FDG-PET (PET) response to pathological response after neoadjuvant chemoradiation (CRT) for locally advanced rectal cancer. Methods and materials Twenty patients with locally advanced rectal cancer were identif
Autor:
Michael Lim Joon, Aldo Rolfo, Daryl Lim Joon, Vincent Khoo, Andrew See, Jarad Martin, Mark Middleton, Steve Medwell
Publikováno v:
Radiography. 14:312-317
Purpose To assess the accuracy and implications on workflow of an online correction electronic portal imaging (EPI) protocol utilising bony anatomy in the online environment and an assessment of three implanted gold seed fiducial markers in the offli
Autor:
Morikatsu Wada, Vincent Khoo, Michael Lim Joon, George Quong, Andrew See, Michael Chao, Andrew M. Scott, E. Zupan, M. Feigen, Daryl Lim Joon, K. Rykers, Cynleen Kai, B. Nguyen
Publikováno v:
Radiotherapy and Oncology. 87:376-382
Purpose To assess the utility of FDG-PET in anal cancer for staging and impact on radiotherapy planning (RTP), response and detection of recurrent disease. Methods and materials Fifty histopathological anal cancer patients were reviewed between 1996
Autor:
Andrew See, John Wong, Aldo Rolfo, Steve Medwell, Michael Lim Joon, Mary Lynton-Moll, Mark Middleton
Publikováno v:
Radiographer. 53:24-28
Given the onset of dose escalation and increased planning target volume (PTV) conformity, the requirement of accurate field placement has also increased. This study compares and contrasts a combination offline/online electronic portal imaging (EPI) d
Autor:
George Quong, Nicole Ng, David Van Gelderen, Jarad Martin, M. Lawlor, Morikatsu Wada, Vincent Khoo, Daryl Lim Joon, Michael R. Grace, Michael Lim Joon
Publikováno v:
Radiotherapy and Oncology. 76:251-256
Background and purpose Adjuvant radiotherapy is currently standard treatment of Stage I seminoma (SOS). The use of computerised tomogram (CT) planning is compared with traditional planning for greater treatment individualisation. Material and methods
Autor:
Tomas Kron, Richard Oates, Suki Gill, Farshad Foroudi, Michal Schneider, Mathias Bressel, Michael Lim Joon
Publikováno v:
Journal of Medical Physics / Association of Medical Physicists of India
This study investigated a relationship between rectum diameter and prostate motion during treatment with a view to reducing planning target volume (PTV) margins for an adaptive protocol. One hundred and ninety-four cone-beam computed tomography (CBCT
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 45:1199-1205
Purpose: To report the clinical features and outcome of patients with primary adenocarcinoma of the anus following radiotherapy with or without chemotherapy. Methods and Materials: A retrospective analysis was performed on 15 patients referred to Pet
Autor:
Narelle McPhee, Richard Oates, Tomas Kron, Farshad Foroudi, Marnie Collins, Michael Lim Joon, Daryl Jones, Michal Schneider
Publikováno v:
Acta oncologica (Stockholm, Sweden). 53(4)
To the Editor,Treatment outcomes for prostate cancer radiotherapy improve with increased dose delivered to the prostate [1]. To enable dose escalation to the prostate without increasing treatment t...
Autor:
Michael Millward, David E. Gyorki, Jill Ainslie, Michael Lim Joon, Grant A. McArthur, Michael A. Henderson
Publikováno v:
Melanoma research. 14(3)
Interferon-alpha2b (IFNalpha2b) is the only form of systemic adjuvant therapy for stage III melanoma with documented survival benefit. Radiotherapy can also be utilized in the adjuvant setting in patients at high risk of nodal basin recurrence. As IF